Replies to post #1541 on Aethlon Medical Inc (AEMD)

[philsdaddy]

The question relates to what is the cost of the cartridge? I think that is a seperate question from what does the treatment cost? I would imagine the initial cartridges will carry a higher price tag, until mass production can be obtained--or, the early cartridges will be sold without profit, or at a loss. Once the Hemopurifier is in use, and with hoped for successful results, word will get out and demand will increase. As demand increases, the price for treatment and cartridges can also increase, even though the cost of manufacture may go down. This product and company have an incredible potential. I have placed my bet on AEMD--this pony hasn't even made it much past the first turn yet--we've still got the backstretch and a long ways to go--no finish line in sight--it's going to be a long and exciting race. I hope we never get to the finish line, as that would mean the race is over. Sorry for the metaphors. I just know the best is yet to come!
Lee

[dannol48]

My thinking ran along the same lines including thoughts about standard cartridges used in Dialysis. I don't think they run cheap.

It does beg the question on the obvious of going "production" and we (as stockholders) have a product going to market. Hope that doesn't sound ugly, but this is a business after all. Same discussion as any drug going to market.